Covaxin Found To Be 77.8% Effective Against Covid In Lancet Study
PUBLISHED ON: November 12, 2021 | Duration: 1 min, 20 sec
Covaxin, a vaccine developed by government's medical research agency and Bharat Biotech International Ltd., was found to have a 77.8% efficacy rate against symptomatic Covid-19 in a long-awaited analysis published in The Lancet.
